ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,698,000 | -87.1% | 1,720,436 | -28.9% | 0.00% | -83.3% |
Q4 2021 | $28,721,000 | -23.7% | 2,419,613 | -0.9% | 0.01% | -25.0% |
Q3 2021 | $37,657,000 | -17.8% | 2,440,476 | +8.0% | 0.02% | -20.0% |
Q2 2021 | $45,803,000 | -6.0% | 2,259,767 | +1.3% | 0.02% | -9.1% |
Q1 2021 | $48,726,000 | -2.6% | 2,230,051 | +17.7% | 0.02% | -4.3% |
Q4 2020 | $50,009,000 | – | 1,893,968 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $27,543,000 | 14.73% |
Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $10,405,000 | 4.35% |
Logos Global Management LP | 3,112,785 | $36,949,000 | 3.81% |
Vivo Capital, LLC | 3,547,030 | $42,103,000 | 2.54% |
Novo Holdings A/S | 2,614,563 | $31,035,000 | 1.47% |
Boxer Capital, LLC | 1,526,048 | $18,114,000 | 0.70% |
HHLR ADVISORS, LTD. | 2,365,064 | $28,073,000 | 0.43% |
Cormorant Asset Management, LP | 521,257 | $6,187,000 | 0.37% |
Baker Brothers Advisors | 2,076,400 | $24,647,000 | 0.12% |
Sofinnova Investments, Inc. | 127,791 | $1,517,000 | 0.09% |